Nicholas Investment Partners’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,514
| Closed | -$713K | – | 246 |
|
|
2024
Q2 | $713K | Hold |
4,514
| – | – | 0.07% | 173 |
|
|
2024
Q1 | $584K | Buy |
4,514
+1,185
| +36% | +$153K | 0.06% | 182 |
|
|
2023
Q4 | $321K | Sell |
3,329
-184,756
| -98% | -$17.8M | 0.04% | 186 |
|
|
2023
Q3 | $22.8M | Buy |
+188,085
| New | +$22.8M | 1.7% | 17 |
|
|
2023
Q2 | – | Sell |
-187,481
| Closed | -$25.8M | – | 210 |
|
|
2023
Q1 | $25.8M | Buy |
187,481
+97,091
| +107% | +$13.4M | 1.96% | 14 |
|
|
2022
Q4 | $11.7M | Buy |
+90,390
| New | +$11.7M | 1.03% | 40 |
|
|
2021
Q1 | – | Sell |
-78,970
| Closed | -$13.5M | – | 207 |
|
|
2020
Q4 | $13.5M | Buy |
78,970
+4,558
| +6% | +$777K | 1.04% | 31 |
|
|
2020
Q3 | $10.5M | Buy |
74,412
+61,844
| +492% | +$8.69M | 1.13% | 30 |
|
|
2020
Q2 | $2.02M | Sell |
12,568
-22,395
| -64% | -$3.59M | 0.41% | 90 |
|
|
2020
Q1 | $3.42M | Sell |
34,963
-753
| -2% | -$73.7K | 0.67% | 58 |
|
|
2019
Q4 | $4.61M | Sell |
35,716
-19,807
| -36% | -$2.56M | 0.47% | 63 |
|
|
2019
Q3 | $4.18M | Buy |
55,523
+1,368
| +3% | +$103K | 0.35% | 111 |
|
|
2019
Q2 | $8.23M | Sell |
54,155
-1,636
| -3% | -$249K | 0.75% | 34 |
|
|
2019
Q1 | $6.65M | Sell |
55,791
-18,311
| -25% | -$2.18M | 0.59% | 37 |
|
|
2018
Q4 | $8.09M | Sell |
74,102
-4,011
| -5% | -$438K | 0.87% | 21 |
|
|
2018
Q3 | $12.6M | Buy |
78,113
+19,570
| +33% | +$3.16M | 1.01% | 11 |
|
|
2018
Q2 | $7.74M | Buy |
+58,543
| New | +$7.74M | 0.54% | 43 |
|
|
2016
Q4 | – | Sell |
-38,504
| Closed | -$2.37M | – | 334 |
|
|
2016
Q3 | $2.37M | Buy |
+38,504
| New | +$2.37M | 0.16% | 244 |
|
|
2013
Q3 | – | Sell |
-51,046
| Closed | -$1.94M | – | 320 |
|
|
2013
Q2 | $1.94M | Buy |
+51,046
| New | +$1.94M | 0.18% | 182 |
|